Hristo L Svilenov

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Venues

Molecular pharmaceutics

mAbs

Protein science : a publication of the Protein Society

Communications biology

Ludwig Maximilian University of Munich

Ludwig Maximilian University of Munich (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ludwig Maximilian University of Munich - Dec 31 2019

Germany

Marie Curie Early Stage Researcher :: Pharmacy

Education History

Ludwig Maximilian University of Munich - Jun 26 2019

Germany

PHD :: Pharmacy

Medical University of Sofia

Bulgaria

MSC

Publications

Johanna Trommer, Florian Lesniowski, Johannes Buchner, Hristo L Svilenov
Specific features of a scaffolding antibody light chain. Protein science : a publication of the Protein Society 33 (5) (2024)
Johanna Trommer, Florian Lesniowski, Johannes Buchner, Hristo L Svilenov
Specific features of a scaffolding antibody light chain. Protein science : a publication of the Protein Society 33 (5) (2024)
Hristo L Svilenov, Paolo Arosio, Tim Menzen, Peter Tessier, Pietro Sormanni
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties. mAbs 15 (1) (2023)
Hristo L Svilenov, Paolo Arosio, Tim Menzen, Peter Tessier, Pietro Sormanni
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties. mAbs 15 (1) (2023)
Hristo L Svilenov, Paolo Arosio, Tim Menzen, Peter Tessier, Pietro Sormanni
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties. mAbs 15 (1) (2023)
Hristo L Svilenov, Florent Delhommel, Till Siebenmorgen, Florian Rührnößl, Grzegorz Maria Popowicz, Alwin Reiter, Michael Sattler, Carsten Brockmeyer, Johannes Buchner
Extrinsic stabilization of antiviral ACE2-Fc fusion proteins targeting SARS-CoV-2. Communications biology 6 (1) (2023)
Hristo L Svilenov, Romina Bester, Julia Sacherl, Ramona M Absmeier, Carsten Peters, Ulrike Protzer, Carsten Brockmeyer, Johannes Buchner
Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants. Communications biology 5 (1) (2022)
Hristo L Svilenov, Julia Sacherl, Ulrike Protzer, Martin Zacharias, Johannes Buchner
Mechanistic principles of an ultra-long bovine CDR reveal strategies for antibody design. Nature communications 12 (1) (2021)
Carolin Berner, Tim Menzen, Gerhard Winter, Hristo L Svilenov
Combining Unfolding Reversibility Studies and Molecular Dynamics Simulations to Select Aggregation-Resistant Antibodies. Molecular pharmaceutics 18 (6) (2021)
Lorenzo Gentiluomo, Hristo L Svilenov, Dillen Augustijn, Inas El Bialy, Maria Laura Greco, Alina Kulakova, Sowmya Indrakumar, Sujata Mahapatra, Marcello Martinez Morales, Christin Pohl, Aisling Roche, Andreas Tosstorff, Robin A Curtis, Jeremy P Derrick, Allan Nørgaard, Tarik A Khan, Günther Herbert Johannes Peters, Alain Pluen, Åsmund Rinnan, Werner W Streicher, Christopher F Van Der Walle, Shahid Uddin, Gerhard Winter, Dierk Roessner, Pernille Harris, Wolfgang Frieß
Advancing Therapeutic Protein Discovery and Development through Comprehensive Computational and Biophysical Characterization. Molecular pharmaceutics 17 (2) (2020)
Hristo L Svilenov, Tim Menzen, Klaus Richter, Gerhard Winter
Modulated Scanning Fluorimetry Can Quickly Assess Thermal Protein Unfolding Reversibility in Microvolume Samples. Molecular pharmaceutics 17 (7) (2020)
Dennis Krieg, Carolin Berner, Gerhard Winter, Hristo L Svilenov
Biophysical Characterization of Binary Therapeutic Monoclonal Antibody Mixtures. Molecular pharmaceutics 17 (8) (2020)

Hristo L Svilenov.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hristo L Svilenov